Clinical Trials on Type 2-diabetes in France

Total 6901 results

Novo Nordisk A/S

Completed

Attitudes and Unmet Needs Among Type 2 Diabetes Patients

Type 2 Diabetes

Korea, Republic of, Mexico, India, United Kingdom, Australia, France, Saudi Arabia
Hospital de Clinicas de Porto Alegre
Federal University of Rio Grande do Sul; Conselho Nacional de Desenvolvimento...

Not yet recruiting

Remote and Intensive Program for Physical Activity Promotion for People With Type 2 Diabetes (The PRACTICE Trial) (PRACTICE)

Type 2 Diabetes

Brazil
University Hospital, Clermont-Ferrand
Laboratory of metabolic adaptation to exercise under Physiological and Physiopathological...

Unknown

HIIE and Abdominal Fat Mass in DT2 Postmenopausal Women

Type 2 Diabetes | Postmenopausal Women | Overweight (BMI > 25)

France
University Hospital, Caen

Completed

Smartguard Use in Real Life : a Longitudinal Study in Patients With Type 1 Diabetes (Smartguard)

Type 1 Diabetes Mellitus Maturity Onset

France
University Hospital, Montpellier

Unknown

SLEEVEDIAB To Explore the Early and Late Metabolic Effects of Sleeve Gastrectomy in Obese Patients (SLEEVEDIAB)

Type 2 Diabetes | Severe Obesity

France
Centre d'Etudes et de Recherche pour l'Intensification...

Completed

Validation of a Predictive Risk Equation for Type 2 Diabetes in Families With Risk (DESCENDANCE)

Type 2 Diabetes

France, Belgium
Boston Therapeutics

Withdrawn

The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic Patients (PAZ320)

Type II Diabetes

France
Lexicon Pharmaceuticals

Completed

Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin

Type 2 Diabetes Mellitus

United States
Centre Hospitalier Sud Francilien

Completed

Impact of the Rapid Normalization of Chronic Hyperglycemia and the Practice of Moderate Physical Activity on the "Receptor Activator of Nuclear Factor-kappa B Ligand / Osteoprotégérine (RANKL / OPG) System in Patients Living With Type II Diabetes (RANKL-GLYC)

Type II Diabetes

France
vTv Therapeutics

Completed

A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Poitiers University Hospital

Unknown

Efficacy of Flash Glucose-Sensing Technology on the Occurrence of Cardiac Arrhythmias Associated With Hypoglycemia

Insulin Treated Type 2 Diabetes With High Risk of Hypoglycemia

France
BHV Pharma
Integrium

Completed

Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes (BRID)

Diabetes Mellitus, Type 2 | Type 2 Diabetes Mellitus

United States
Centre Hospitalier Universitaire Dijon

Completed

Influence of Glitazones on the Vasodilatory Effect of High-density Lipoprotein (HDL) Lipoproteins

Type 2 Diabetes

France
University Hospital, Angers

Unknown

Hope Theory as Ability Determinant to Permanently Change the Adapted Physical Activity (APA) in Type 2 Diabetic Patients (APADIAB-ESPOIR)

Type 2 Diabetes

France
Sanofi

Completed

Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine) (GALATEE)

Type 2 Diabetes

France
University Hospital Center of Martinique
Clinique Antilles-Guyane

Unknown

Exercise Consultation for Type 2 Diabetes Patients in Real Life (APDT 2)

Diabetes Mellitus, Type 2

France
Hospices Civils de Lyon

Not yet recruiting

Impact of Obesity, Chronic Kidney Disease and Type 2 Diabetes on Human Urinary Stem Cells (URISTEM)

Obesity | Chronic Kidney Diseases | Diabetes type2 | Stem Cells

France
AstraZeneca
Eli Lilly and Company

Completed

CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy

Type 2 Diabetes Mellitus

Sweden, Germany, Greece, Denmark, France
Eli Lilly and Company

Completed

A Study for Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Brazil, Canada, Mexico, India, Australia, China, Korea, Republic of
Hospital de Clinicas de Porto Alegre

Unknown

Effect of Nutritional Counseling Based on Diet Quality on Metabolic Control in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Brazil
Hospital de Clinicas de Porto Alegre
Federal University of Rio Grande do Sul; Coordenação de Aperfeiçoamento de...

Unknown

Glycemic and Satiety Response to Fiber and Glycemic Index of Meals in Diabetes

Type 2 Diabetes Mellitus

Brazil
vTv Therapeutics

Completed

A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Sanofi

Completed

Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications (SENIOR)

Type 2 Diabetes Mellitus

United States, Australia, Spain, Korea, Republic of, Hungary, Mexico, Italy, Poland, Argentina, Canada, Colombia, France, Germany, Japan, Peru, Romania, Sweden, United Kingdom
Theracos

Completed

Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States, Canada
Gasherbrum Bio, Inc

Completed

Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus

Overweight or Obesity | Type2 Diabetes Mellitus

United States
Assistance Publique - Hôpitaux de Paris
Recherche Clinique Paris Descartes Necker Cochin Sainte Anne

Suspended

Impact of Rheumatoid Arthritis on the Course of Type 2 Diabetes During a Longitudinal Follow-up of 5 Years (INSPIRED)

Type 2 Diabetes

France
AstraZeneca
Eli Lilly and Company

Completed

Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)

Type 2 Diabetes Mellitus

United States, Czech Republic, France, Korea, Republic of, Russian Federation, Spain, Mexico, Australia, Belgium, Denmark, Germany, Hungary, Netherlands, Puerto Rico, Greece, Taiwan
Centre d'Etudes et de Recherche pour l'Intensification...

Terminated

Skin Samples of Diabetic Patients and Healthy Volunteers Collection

Type 2 Diabetes

France
Bayer

Completed

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN)

Diabetic Nephropathies

Hong Kong, Australia, Spain, Portugal, United States, France, Canada, Netherlands, Austria, Finland, Poland, Taiwan, Hungary, Israel, Italy, South Africa, Sweden, Bulgaria, Germany, Denmark, Czechia, Korea, Republic of, Norway
University Hospital, Montpellier

Recruiting

Interest of FSL 2 in Recently Diagnosed Type 2 Diabetic Patients (FREEDIA)

Type 2 Diabetes | Endocrinology

France
AstraZeneca
Eli Lilly and Company

Completed

Exenatide Versus Glimepiride in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Czech Republic, Italy, Poland, Spain, United Kingdom, Germany, Hungary, Finland, Mexico, Austria, France, Israel, Switzerland, Ireland
Theracos

Completed

Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Type 2 Diabetes Mellitus

United States, Japan, Czechia, Hungary, Poland, Spain
AstraZeneca
Eli Lilly and Company

Completed

Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Australia, France, Italy, Korea, Republic of, Mexico, Spain, Poland, Romania, South Africa, Argentina, Austria, Belgium, Germany, Hungary, Israel, Slovakia, Greece, India, Taiwan, Canada, Czech Republic
AstraZeneca
Eli Lilly and Company

Completed

A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Sweden, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Estonia, Romania, Finland, Netherlands, Argentina, Belgium, Germany, Portugal, United Kingdom, Greece, France, Puerto Rico
AstraZeneca

Completed

Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus (DURATION-NEO-2)

Diabetes Type 2

United States
Assistance Publique - Hôpitaux de Paris

Terminated

Evaluation of Continuous Glucose Monitoring in Patients With ACS and Type 2 Diabetes in ICU (EVASION)

Type 2 Diabetes | Acute Coronary Syndrome

France
University Hospital, Rouen

Completed

Mechanisms of Endothelial Dysfunction in Type 2 Diabetes (DIAB-EETs)

Diabetes Mellitus, Type 2

France
Lille Catholic University

Completed

Educational Intervention Targeting Statin Therapy and Compliance in Diabetic Patients (STADIA)

Type II Diabetes

France
AstraZeneca
Eli Lilly and Company

Completed

Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

Type 2 Diabetes Mellitus

United States, Brazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Turkey, United Kingdom, South Africa, Argentina, Canada, Germany, Hungary, Israel, Romania, Slovakia, India, Belgium, France, Puerto Rico
Hospices Civils de Lyon

Completed

Effects of Docosahexaenoic Acid (DHA) on Cardiovascular Disease on Diabetic Patients

Type 2 Diabetes

France
Centre Hospitalier Universitaire Dijon

Completed

Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging (LICAS-MR)

Type II Diabetes

France
Nantes University Hospital

Recruiting

Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus (L-FibroT2DM)

Diabetes Mellitus, Type 2 | NAFLD | NASH

France
Assistance Publique - Hôpitaux de Paris

Unknown

Coaching of Diabetic Patients After Hospital Discharge (SORTIDIAB)

Type 2 Diabetes

France
Eli Lilly and Company

Completed

A Study of LY3025876 in Participants With Diabetes

Type 2 Diabetes Mellitus

United States
Sanofi

Completed

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine (GetGoal-Duo1)

Type 2 Diabetes Mellitus

United States, Argentina, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, France, Germany, Hungary, India, Israel, Italy, Malaysia, Mexico, Netherlands, Poland, Puerto Rico, Romania, Russian Federation, South Africa, Swed... and more
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Fecal Microbiota Transfer to Improve Diabetes Control Post-bariatric Surgery (DRIFTER)

Type 2 Diabetes | Bariatric Surgery

France
Assistance Publique Hopitaux De Marseille

Completed

Acute Effect of Intensive Insulin Infusion on Intestinal Triglyceride-rich-lipoprotein-apoB48 Metabolism in Type 2 Diabetic Patients

Type 2 Diabetes

France
Bristol-Myers Squibb
Merck Sharp & Dohme LLC

Completed

Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes

Type 2 Diabetes Mellitus

United States, Argentina, Canada, Mexico, Peru, Taiwan, Australia, Philippines, Thailand, Brazil, Chile, India, Russian Federation, Ukraine
Assistance Publique - Hôpitaux de Paris

Completed

Therapeutic Education of the Patients Diabetics Imprisoned at the Paris Jail (EPRIDIA)

Type 1 or 2 Diabetes

France
Sanofi

Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period (LixiLan-G)

Type 2 Diabetes Mellitus

Estonia, Italy, Israel, United States, Canada, Germany, Romania, Slovakia, Spain

Clinical Trials on Type 2-diabetes in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations